Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 2
1968 4
1969 3
1970 3
1972 2
1973 4
1974 3
1975 5
1976 2
1977 2
1978 1
1979 4
1980 2
1981 2
1982 4
1983 4
1984 3
1985 2
1986 2
1987 1
1988 8
1989 8
1990 6
1991 3
1992 2
1993 2
1995 2
1996 2
1997 7
1998 1
2000 2
2001 4
2002 4
2003 7
2004 4
2005 9
2006 4
2007 5
2008 2
2009 10
2010 12
2011 8
2012 5
2013 20
2014 23
2015 12
2016 20
2017 18
2018 18
2019 18
2020 17
2021 16
2022 13
2023 13
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

333 results

Results by year

Filters applied: . Clear all
Page 1
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Ando Y, Nishiyama H, Shimodaira H, Takano N, Sakaida E, Matsumoto K, Nakanishi K, Sakai H, Tsukamoto S, Komine K, Yasuda Y, Kato T, Fujiwara Y, Koyama T, Kitamura H, Kuwabara T, Yonezawa A, Okumura Y, Yakushijin K, Nozawa K, Goto H, Matsubara T, Hoshino J, Yanagita M; Committee of Clinical Practice Guidelines for the Management of Kidney Disease During Anticancer Drug Therapy 2022. Ando Y, et al. Among authors: takano n. Int J Clin Oncol. 2023 Oct;28(10):1315-1332. doi: 10.1007/s10147-023-02382-2. Epub 2023 Jul 16. Int J Clin Oncol. 2023. PMID: 37453935
Pulmonary manifestation of inflammatory bowel disease: Two case reports.
Suzuki A, Noro R, Omori J, Terasaki Y, Tanaka T, Fujita K, Takano N, Sakurai Y, Suga M, Hayashi A, Okamura K, Saito Y, Kasahara K, Iwakiri K, Kubota K, Seike M. Suzuki A, et al. Among authors: takano n. Respir Med Case Rep. 2023 Aug 22;45:101914. doi: 10.1016/j.rmcr.2023.101914. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37719886 Free PMC article.
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer.
Yamamoto T, Hayashida T, Masugi Y, Oshikawa K, Hayakawa N, Itoh M, Nishime C, Suzuki M, Nagayama A, Kawai Y, Hishiki T, Matsuura T, Naito Y, Kubo A, Yamamoto A, Yoshioka Y, Kurahori T, Nagasaka M, Takizawa M, Takano N, Kawakami K, Sakamoto M, Wakui M, Yamamoto T, Kitagawa Y, Kabe Y, Horisawa K, Suzuki A, Matsumoto M, Suematsu M. Yamamoto T, et al. Among authors: takano n. Cancer Res. 2024 Apr 1;84(7):1065-1083. doi: 10.1158/0008-5472.CAN-23-2266. Cancer Res. 2024. PMID: 38383964 Free PMC article.
Three cases of distomolars.
Ohata H, Hayashi K, Iwamoto M, Muramatsu K, Watanabe A, Narita M, Suga K, Takano N, Shibahara T. Ohata H, et al. Among authors: takano n. Bull Tokyo Dent Coll. 2013;54(4):259-64. doi: 10.2209/tdcpublication.54.259. Bull Tokyo Dent Coll. 2013. PMID: 24521552 Free article. Review.
Indole alkaloids in medicine.
Ban Y, Murakami Y, Iwasawa Y, Tsuchiya M, Takano N. Ban Y, et al. Among authors: takano n. Med Res Rev. 1988 Apr-Jun;8(2):231-308. doi: 10.1002/med.2610080205. Med Res Rev. 1988. PMID: 3288822 Review. No abstract available.
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022.
Yanagita M, Muto S, Nishiyama H, Ando Y, Hirata S, Doi K, Fujiwara Y, Hanafusa N, Hatta T, Hoshino J, Ichioka S, Inoue T, Ishikura K, Kato T, Kitamura H, Kobayashi Y, Koizumi Y, Kondoh C, Matsubara T, Matsubara K, Matsumoto K, Okuda Y, Okumura Y, Sakaida E, Shibagaki Y, Shimodaira H, Takano N, Uchida A, Yakushijin K, Yamamoto T, Yamamoto K, Yasuda Y, Oya M, Okada H, Nangaku M, Kashihara N. Yanagita M, et al. Among authors: takano n. Clin Exp Nephrol. 2024 Feb;28(2):85-122. doi: 10.1007/s10157-023-02415-0. Epub 2023 Oct 25. Clin Exp Nephrol. 2024. PMID: 37878114 Free PMC article. No abstract available.
Countermeasure and opportunistic screening systems for oral cancer.
Morikawa T, Shibahara T, Takano M, Iwamoto M, Takaki T, Kasahara K, Nomura T, Takano N, Katakura A. Morikawa T, et al. Among authors: takano n. Oral Oncol. 2021 Jan;112:105047. doi: 10.1016/j.oraloncology.2020.105047. Epub 2020 Oct 22. Oral Oncol. 2021. PMID: 33129059 Free article.
333 results